Pancreatic Cancer Research

ResearcherInsermActive in the last 2 years

Natalia B. Prevarskaya

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0316-197X; OpenAlex author ID A5007220163. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
33
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 7

  1. pH-Dependent Microenvironmental Ionic Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1111/apha.70183↗
  2. Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its Sensitivity to Gemcitabine and C18-Gemc… Co-author DOI 10.3390/cells13090730↗
  3. Acidic Growth Conditions Promote Epithelial-to-Mesenchymal Transition to Select More Aggressive PDAC Cell Phenotypes In Vitro. Co-author DOI 10.3390/cancers15092572↗
  4. TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics. Co-author DOI 10.3390/cancers15245769↗
  5. ORAI3 silencing alters cell proliferation and promotes mitotic catastrophe and apoptosis in pancreatic adenocarcinoma. Last author DOI 10.1016/j.bbamcr.2021.119023↗
  6. Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression. First author DOI 10.3390/cells10051021↗
  7. Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma. Last author DOI 10.1016/j.bbamcr.2014.02.012↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Albrecht Schwab · 4 shared papers, 2021–2026 · strength 0.71
  2. Tiago M. A. Carvalho · 3 shared papers, 2023–2026 · strength 0.53
  3. Stephan J. Reshkin · 3 shared papers, 2023–2026 · strength 0.53
  4. Rosa Angela Cardone · 3 shared papers, 2023–2026 · strength 0.53
  5. Madelaine Magalì Audero · 3 shared papers, 2023–2026 · strength 0.53
  6. Alessandra Fiorio Pla · 3 shared papers, 2023–2026 · strength 0.53
  7. Gonçalo Mesquita · 2 shared papers, 2021–2023 · strength 0.36
  8. V’yacheslav Lehen’kyi · 2 shared papers, 2021–2023 · strength 0.36
  9. Zoltán Pethő · 2 shared papers, 2023–2026 · strength 0.36
  10. Pawel Swietach · 1 shared paper, 2026 · strength 0.19
  11. Sofie Hagelund · 1 shared paper, 2026 · strength 0.19
  12. Verena Hofschröer · 1 shared paper, 2026 · strength 0.19
  13. Laura Mezzanotte · 1 shared paper, 2026 · strength 0.19
  14. Torsten Hechler · 1 shared paper, 2026 · strength 0.19
  15. Julie Schnipper · 1 shared paper, 2026 · strength 0.19
  16. Wiktoria Błaszczak · 1 shared paper, 2026 · strength 0.19
  17. Frauke Alves · 1 shared paper, 2026 · strength 0.19
  18. Ganga Deshar · 1 shared paper, 2026 · strength 0.19
  19. Ivana Novak · 1 shared paper, 2026 · strength 0.19
  20. Renata Ialchina · 1 shared paper, 2026 · strength 0.19
  21. Luis A. Pardo · 1 shared paper, 2026 · strength 0.19
  22. Roisin McMorrow · 1 shared paper, 2026 · strength 0.19
  23. Anna Trauzold · 1 shared paper, 2026 · strength 0.19
  24. Halima Ouadid‐Ahidouch · 1 shared paper, 2026 · strength 0.19
  25. Annarosa Arcangeli · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.